🔬 Now at Pharmidex: The 8HUM Model
July 21, 2025
Pharmidex is proud to offer access to the 8HUM model genetically humanized for 33 liver CYP enzymes responsible for metabolizing 90% of human drugs.
✅ Human-relevant metabolism data
✅ Supports IND-enabling & regulatory studies
✅ Ideal for metabolite profiling, DDI risk & toxicity assessment
By integrating 8HUM into our DMPK and in vivo studies, we deliver deeper, more predictive insights for safer, smarter drug development.
📩 Contact us to see how 8HUM can support your project.
#Pharmidex #8HUM #DrugMetabolism #DMPK #PreclinicalResearch #InVivoPharmacology #DrugDevelopment
Pharmidex is pleased to share that Ash Alavijeh , our Head of Operations, will be attending the Life Sciences Wallonia Business Forum this evening at the Residence of the Belgian Ambassador. Hosted by the Economic Counsellor of Belgium-Wallonia Investment & Trade, the event brings together leading organisations across the European life sciences sector to explore how Wallonia supports international growth both financially and strategically. We look forward to connecting with international partners and exploring opportunities for collaboration and innovation in the European life sciences ecosystem.
Pharmidex is proud to sponsor the SMR meeting Target Identification and Validation in Drug Discovery
We’re excited that Janette Dalay Robertson (Business Development Manager) and Ian Knowles (Head of Respiratory) will attend, eager to meet attendees, share ideas and explore new collaborations to advance drug discovery and development. At Pharmidex , we know robust target validation is key to successful therapeutics. Our expertise in biomarker analysis, histology, in vivo models, and autoimmune disease research supports innovation across translational medicine.
Pharmidex is delighted to announce our joint poster with VasoDynamics Ltd at Scotland’s Health Research and Innovation Conference on October 23rd in Edinburgh! We’re proud to be part of this inspiring event, organised by NHS Scotland and CSO Scotland , which brings together the brightest minds driving progress in health research, innovation, and life sciences. 📍 Visit our stand to learn more about our collaborative work. A printout of the poster will be available. Mo Alavijeh (FRSC, FRSM ) is looking forward to meeting attendees and discussing new opportunities for partnership and discovery. Together with VasoDynamics Ltd , we’re advancing science through collaboration and innovation. 🔗 Learn more about Pharmidex : www.pharmidex.com
